Breast Cancer Research and Treatment

, Volume 109, Issue 1, pp 47–54

FBXW7 and DNA copy number instability

  • Kristin N. Byrd
  • Bing Huey
  • Ritu Roydasgupta
  • Jane Fridlyand
  • Antoine M. Snijders
  • Donna G. Albertson
Preclinical Study


SKP1-cullin-F-box protein (SCF) type ubiquitin ligases degrade proteins controlling the G1/S transition. Deficiency for FBXW7 (also known as hCDC4), which encodes the F-box protein of the SCF type ubiquitin ligase is associated with genomic instability. Here, we investigated the association of FBXW7 deficiency with chromosomal instability in breast cancer. We screened 49 tumors previously profiled by array CGH for mutations in conserved regions of FBXW7, but found no mutations. Copy number loss of FBXW7, however was associated with enhanced genomic instability in the Complex breast tumor subtype, but instability may not be due to FBXW7 haploinsufficiency, since transcript levels were not reduced in tumors with loss of the locus, whereas reduced expression was observed for other neighboring genes involved in maintenance of genome stability. We also investigated whether cells deficient for FBXW7 showed enhanced instability by challenging cells with methotrexate and assessing numbers of genomic alterations arising in resistant cells. Although methotrexate resistant colonies formed at high frequencies in HCT116 FBXW7+/ and HCT116 FBXW7−/ cells compared to parental HCT116, few copy number alterations were detected in the resistant cells. Taken together these studies suggest that FBXW7 deficiency is unlikely to contribute to the extensive copy number aberrations associated with breast and possibly other tumor types.


FBXW7 Genome instability Array CGH 

Supplementary material

10549_2007_9623_MOESM1_ESM.doc (186 kb)
Supplemental Table 1Mutational analysis of FBXW7 in ductal invasive breast tumors. Exons 5-9 and 11 were sequenced in 62 ductal invasive breast tumors analyzed previously by array CGH (Fridlyand et al., 2006). No mutations were found in FBXW7, although single base changes were found in the introns before exon 5 in S0041, exon 7 in S1551, and exon 11 in S0065 (DOC 186 kb)
10549_2007_9623_MOESM2_ESM.xls (1.1 mb)
Supplemental Table 2(XLS 1128 kb)


  1. 1.
    Cahill DP, Lengauer C, Yu J et al (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392:300–303PubMedCrossRefGoogle Scholar
  2. 2.
    Wang Z, Cummins JM, Shen D et al (2004) Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Res 64:2998–3001PubMedCrossRefGoogle Scholar
  3. 3.
    Spruck CH, Strohmaier H, Sangfelt O et al (2002) Hcdc4 gene mutations in endometrial cancer. Cancer Res 62:4535–4539PubMedGoogle Scholar
  4. 4.
    Rajagopalan H, Jallepalli PV, Rago C et al (2004) Inactivation of hcdc4 can cause chromosomal instability. Nature 428:77–81PubMedCrossRefGoogle Scholar
  5. 5.
    Moberg KH, Mukherjee A, Veraksa A et al (2004) The drosophila f box protein archipelago regulates dmyc protein levels in vivo. Curr Biol 14:965–974PubMedCrossRefGoogle Scholar
  6. 6.
    Welcker M, Orian A, Jin J et al (2004) The fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-myc protein degradation. Proc Natl Acad Sci U S A 101:9085–9090PubMedCrossRefGoogle Scholar
  7. 7.
    Yada M, Hatakeyama S, Kamura T et al (2004) Phosphorylation-dependent degradation of c-myc is mediated by the f-box protein fbw7. Embo J 23:2116–2125PubMedCrossRefGoogle Scholar
  8. 8.
    Koepp DM, Schaefer LK, Ye X et al (2001) Phosphorylation-dependent ubiquitination of cyclin e by the scffbw7 ubiquitin ligase. Science 294:173–177PubMedCrossRefGoogle Scholar
  9. 9.
    Moberg KH, Bell DW, Wahrer DC et al (2001) Archipelago regulates cyclin e levels in drosophila and is mutated in human cancer cell lines. Nature 413:311–316PubMedCrossRefGoogle Scholar
  10. 10.
    Strohmaier H, Spruck CH, Kaiser P et al (2001) Human f-box protein hcdc4 targets cyclin e for proteolysis and is mutated in a breast cancer cell line. Nature 413:316–322PubMedCrossRefGoogle Scholar
  11. 11.
    Tsunematsu R, Nakayama K, Oike Y et al (2004) Mouse fbw7/sel-10/cdc4 is required for notch degradation during vascular development. J Biol Chem 279:9417–9423PubMedCrossRefGoogle Scholar
  12. 12.
    Wu G, Lyapina S, Das I et al (2001) Sel-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol 21:7403–7415PubMedCrossRefGoogle Scholar
  13. 13.
    Mao JH, Perez-Losada J, Wu D et al (2004) Fbxw7/cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 432:775–779PubMedCrossRefGoogle Scholar
  14. 14.
    Rajagopalan H, Lengauer C (2004) Hcdc4 and genetic instability in cancer. Cell Cycle 3:693–694PubMedGoogle Scholar
  15. 15.
    Kimura T, Gotoh M, Nakamura Y et al (2003) Hcdc4b, a regulator of cyclin e, as a direct transcriptional target of p53. Cancer Sci 94:431–436PubMedCrossRefGoogle Scholar
  16. 16.
    Minella AC, Clurman BE (2005) Mechanisms of tumor suppression by the scf(fbw7). Cell Cycle 4:1356–1359PubMedGoogle Scholar
  17. 17.
    Gallahan D, Callahan R (1997) The mouse mammary tumor associated gene int3 is a unique member of the notch gene family (notch4). Oncogene 14:1883–1890PubMedCrossRefGoogle Scholar
  18. 18.
    Gallahan D, Jhappan C, Robinson G et al (1996) Expression of a truncated int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res 56:1775–1785PubMedGoogle Scholar
  19. 19.
    Jhappan C, Gallahan D, Stahle C et al (1992) Expression of an activated notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev 6:345–355PubMedCrossRefGoogle Scholar
  20. 20.
    Robbins J, Blondel BJ, Gallahan D et al (1992) Mouse mammary tumor gene int-3: A member of the notch gene family transforms mammary epithelial cells. J Virol 66:2594–2599PubMedGoogle Scholar
  21. 21.
    Fridlyand J, Snijders AM, Ylstra B et al (2006) Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 6:96PubMedCrossRefGoogle Scholar
  22. 22.
    Kwak EL, Moberg KH, Wahrer DC et al (2005) Infrequent mutations of archipelago (hago, hcdc4, fbw7) in primary ovarian cancer. Gynecol Oncol 98:124–128PubMedCrossRefGoogle Scholar
  23. 23.
    Yan T, Wunder JS, Gokgoz N et al (2006) Hcdc4 variation in osteosarcoma. Cancer Genet Cytogenet 169:138–142PubMedCrossRefGoogle Scholar
  24. 24.
    Shih IM, Zhou W, Goodman SN et al (2001) Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61:818–822PubMedGoogle Scholar
  25. 25.
    Kemp Z, Rowan A, Chambers W et al (2005) Cdc4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability. Cancer Res 65:11361–11366PubMedCrossRefGoogle Scholar
  26. 26.
    Willmarth NE, Albertson DG Ethier SP (2004) Chromosomal instability and lack of cyclin e regulation in hcdc4 mutant human breast cancer cells. Breast Cancer Res 6:R531–539PubMedCrossRefGoogle Scholar
  27. 27.
    Snijders AM, Fridlyand J, Mans DA et al (2003) Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene 22:4370–4379PubMedCrossRefGoogle Scholar
  28. 28.
    Snijders AM, Nowak N, Segraves R et al (2001) Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29:263–264PubMedCrossRefGoogle Scholar
  29. 29.
    Olshen AB, Venkatraman ES, Lucito R et al (2004) Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5:557–572PubMedCrossRefGoogle Scholar
  30. 30.
    Willenbrock H Fridlyand J (2005) A comparison study: applying segmentation to array cgh data for downstream analyses. Bioinformatics 21:4084–4091CrossRefGoogle Scholar
  31. 31.
    Hartigan JA (1975) Clustering algorithms. Wiley, New YorkGoogle Scholar
  32. 32.
    Bennin DA, Don AS, Brake T et al (2002) Cyclin g2 associates with protein phosphatase 2a catalytic and regulatory b’ subunits in active complexes and induces nuclear aberrations and a g1/s phase cell cycle arrest. J Biol Chem 277:27449–27467PubMedCrossRefGoogle Scholar
  33. 33.
    Kim Y, Shintani S, Kohno Y et al (2004) Cyclin g2 dysregulation in human oral cancer. Cancer Res 64:8980–8986PubMedCrossRefGoogle Scholar
  34. 34.
    Mahjoub MR, Trapp ML Quarmby LM (2005) Nima-related kinases defective in murine models of polycystic kidney diseases localize to primary cilia and centrosomes. J Am Soc Nephrol 16:3485–3489PubMedCrossRefGoogle Scholar
  35. 35.
    Banerjee D, Mayer-Kuckuk P, Capiaux G et al (2002) Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 1587:164–173PubMedGoogle Scholar
  36. 36.
    Koi M, Umar A, Chauhan DP et al (1994) Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces n-methyl-n’-nitro-n-nitrosoguanidine tolerance in colon tumor cells with homozygous hmlh1 mutation. Cancer Res 54:4308–4312PubMedGoogle Scholar
  37. 37.
    Li G, Nelsen C Hendrickson EA (2002) Ku86 is essential in human somatic cells. Proc Natl Acad Sci U S A 99:832–837PubMedGoogle Scholar
  38. 38.
    Traverso G, Bettegowda C, Kraus J et al (2003) Hyper-recombination and genetic instability in blm-deficient epithelial cells. Cancer Res 63:8578–8581PubMedGoogle Scholar
  39. 39.
    Karow JK, Wu L Hickson ID (2000) Recq family helicases: roles in cancer and aging. Curr Opin Genet Dev 10:32–38PubMedCrossRefGoogle Scholar
  40. 40.
    Sjoblom T, Jones S, Wood LD et al (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268–274PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Kristin N. Byrd
    • 1
    • 2
  • Bing Huey
    • 2
    • 3
  • Ritu Roydasgupta
    • 2
  • Jane Fridlyand
    • 2
    • 4
  • Antoine M. Snijders
    • 1
    • 2
  • Donna G. Albertson
    • 1
    • 2
    • 3
  1. 1.Cancer Research InstituteUniversity of California San FranciscoSan FranciscoUSA
  2. 2.Comprehensive Cancer CenterUniversity of California San FranciscoSan FranciscoUSA
  3. 3.Department of Laboratory MedicineUniversity of California San FranciscoSan FranciscoUSA
  4. 4.Department of Epidemiology and BiostatisticsUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations